ReviewWiley interdisciplinary reviews. Nanomedicine and nanobiotechnology
Principles of Biocompatible Nanotube Design for High-Performance Biomaterials.
Review in Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Principles of Biocompatible Nanotube Design for High-Performance Biomaterials.Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnologyReview
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Nanotubes are one-dimensional tubular structures characterized by nanoscale radial dimensions and micrometer-scale axial lengths. Their hollow inner cavity confers a high specific surface area and distinctive physicochemical properties, enabling remarkable potential in drug delivery, disease diagnostics, and tissue engineering. Extensive research into their biocompatibility and degradability establishes a solid foundation for further development and rational design. A synthesis of current data across relevant systems, including carbon nanotubes (CNTs), boron nitride nanotubes (BNNTs), titanium dioxide nanotubes (TiNTs), halloysite nanotubes (HNTs), anodic aluminium oxide nanotubes (AAOs), lipid nanotubes (LNTs), and polymeric nanotubes (PNTs), reveals how structural features and physicochemical properties govern biological responses and functional performance. This integration supports a unified "structure-property-bioresponse-function" framework, offering a conceptual roadmap and general design principles to guide the next generation of nanotube-based biomaterials.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.